IMMUNAI
Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. The company is located in New York City, San Francisco, and Tel Aviv, Israel.
IMMUNAI
Industry:
Analytics Artificial Intelligence Biotechnology Machine Learning Therapeutics
Founded:
2018-12-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.immunai.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
295 M USD
Technology used in webpage:
SPF Domain Not Resolving Google Apps For Business COVID-19 DMARC MailChimp SPF Fastly Hosted Fastly Load Balancer Google DNS Google Domains
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Metagenomi
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-07-29 | Nebion | Nebion acquired by Immunai | N/A |
| 2021-03-25 | Dropprint Genomics | Dropprint Genomics acquired by Immunai | N/A |
Investors List
Piedmont Capital Investments
Piedmont Capital Investments investment in Series B - Immunai
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Immunai
Koch Disruptive Technologies
Koch Disruptive Technologies investment in Series B - Immunai
8VC
8VC investment in Series B - Immunai
Talos VC
Talos VC investment in Series B - Immunai
Schusterman Foundation
Schusterman Foundation investment in Series A - Immunai
Duquesne Family Office
Duquesne Family Office investment in Series A - Immunai
Viola Group
Viola Group investment in Series A - Immunai
Dexcel Pharma
Dexcel Pharma investment in Series A - Immunai
TLV Partners
TLV Partners investment in Series A - Immunai
Official Site Inspections
http://www.immunai.com Semrush global rank: 2.68 M Semrush visits lastest month: 6.22 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
